Founded in 1986, Shire Pharmaceuticals is a global biopharmaceutical company with major operations in the United States, United Kingdom and Switzerland. The organization is structured across three businesses—human genetic therapies, regenerative medicine, and specialty pharmaceuticals.
Shire employs over 5,000 people in 29 countries, and in 2011 reported revenues of more than $4 billion. Shire has treatments available in nearly 50 countries.